Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients.

Rianne A WeersinkMarianna AbadierAnthonius de Boer Katka TaxisSander D Borgsteede

Published in: British journal of clinical pharmacology (2020)

Community pharmacists regularly evaluate the safety of medication in patients with hepatic impairment, yet their level of knowledge was insufficient and additional education is needed. Pharmacists experienced several difficulties in providing pharmaceutical care. If these issues are resolved, pharmacists can play a more active role in ensuring medication safety in their patients with hepatic impairment.

Keyphrases

healthcare
end stage renal disease
general practice
chronic kidney disease
ejection fraction
mental health
newly diagnosed
prognostic factors
palliative care
primary care
peritoneal dialysis
emergency department
chronic pain
affordable care act